A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

Completed · Phase 3

Conditions studied: Chronic Hepatitis B

In brief

The purpose of this clinical research study is to assess the safety and effectiveness of switching to entecavir compared to continued lamivudine in patients with chronic hepatitis B.

Key facts

Study ID
NCT00036608
Run by
Bristol-Myers Squibb
Starts
2002-01-01
Expected to finish
2005-02-01
Last updated by the study team
2011-04-14

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.